Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Temporal bone chemodectomas--comparing surgery and radiation therapy.

S C Springate1, D Haraf, R R Weichselbaum

  • 1Department of Radiation and Cellular Oncology, Michael Reese/U. of Chicago, Center for Radiation Therapy.

Oncology (Williston Park, N.Y.)
|April 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prompt-directed ambient artificial intelligence for automated multidisciplinary tumor board documentation.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers.

Scientific reports·2016
Same author

Autologous Bone Marrow Transplantation Followed by Involved Field Radiotherapy in Patients with Relapsed or Refractory Hodgkin's Disease.

Leukemia & lymphoma·2016
Same author

Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy.

Oncogene·2016
Same author

Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome.

British journal of cancer·2015
Same author

Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor.

Oncogene·2014
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

For temporal bone chemodectomas, radiation therapy offers similar local control to surgery but with significantly lower complication rates. Radiation alone is recommended as a primary treatment for glomus jugulare tumors.

Area of Science:

  • Otolaryngology
  • Neurosurgery
  • Radiation Oncology

Background:

  • Chemodectomas, also known as glomus tumors, are rare neuroendocrine neoplasms often found in the temporal bone.
  • Treatment of these tumors involves a balance between local control and minimizing treatment-related morbidity.

Purpose of the Study:

  • To compare the efficacy and safety of different therapeutic approaches for temporal bone chemodectomas.
  • To determine the optimal primary treatment strategy for glomus jugulare tumors.

Main Methods:

  • Literature review of published series on curative treatments for temporal bone chemodectomas.
  • Calculation of local control and complication rates for surgery alone, radiation with surgery, and radiation alone.

Main Results:

Related Experiment Videos

  • Local control rates were comparable across all three treatment groups: surgery alone (86%), radiation with surgery (90%), and radiation alone (93%).
  • Surgical excision of glomus jugulare lesions was associated with a high rate of treatment-related morbidity.
  • Serious sequelae from radiation therapy were infrequent.

Conclusions:

  • Radiation therapy demonstrates comparable local control rates to surgery for temporal bone chemodectomas.
  • Radiation therapy is associated with significantly lower morbidity compared to surgical interventions.
  • Radiation therapy should be considered the primary treatment modality for glomus jugulare tumors due to its favorable risk-benefit profile.